Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Earnings for Allogene Therapeutics (ALLO)
Earnings in 2023 (TTM): -$0.32 B
According to Allogene Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.32 B. In 2022 the company made an earning of -$0.34 B a decrease over its 2021 earnings that were of -$0.26 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Allogene Therapeutics from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.32 B | -6.25% |
| 2022 | -$0.34 B | 31.14% |
| 2021 | -$0.26 B | 2.23% |
| 2020 | -$0.26 B | 25.98% |
| 2019 | -$0.2 B | -4.68% |
| 2018 | -$0.21 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -64.77% | 🇺🇸 USA |